Abstract. Acute promyelocytic leukemia is frequently associated with dizziness, fever, nausea, hematochezia and anemia. Blue light, or light with wavelengths of 400-480 nm, transmits high levels of energy. The aim of the present study was to determine the pro-apoptotic effects of blue light (wavelength, 456 nm; radiation power, 0.25 mW/cm 2 ) and the underlying mechanisms in a human promyelocytic leukemia cell line (HL60). Blue light reduced the viability and enhanced the mortality of HL60 cells in a time-dependent manner. Exposure to blue light for 24 h caused depolarization of the mitochondrial membrane potential and the overproduction of reactive oxygen species in HL60 cells. In a nude mouse model, 9-day exposure to blue light markedly suppressed the growth of HL60-xenografted tumors; however, it had no effect on hepatic and renal tissues. In addition, blue light abrogated the expression of B-cell lymphoma (Bcl)-2 and Bcl extra-long, while enhancing the levels of Bcl-2-associated X protein, cytochrome c, and cleaved caspases-3 and -9 in tumor tissues. The results suggested that the pro-apoptotic effects of blue light in human promyelocytic leukemia cells may be associated with the mitochondrial apoptosis signaling pathway.
Introduction
Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML), accounts for 46% of leukemia cases and is frequently associated with dizziness, fever, nausea, hematochezia and anemia (1, 2) . Currently, the standard treatment for APL is combination chemotherapy, which may cause gastrointestinal effects, multi-organ impairment and alopecia. Therefore, new therapeutic options for APL are urgently needed. Near-infrared light can easily penetrate the skin and is absorbed deeply into tissues (3) . Accordingly, the ability of a near-infrared (NIR) laser and hollow gold nanospheres (HAuNSs) to modulate the release of anticancer agents was tested using the antitumor drug paclitaxel, which exhibits surface plasmon absorbance in the NIR region and significant anti-tumor effects, demonstrated strong cytotoxicity and reduced tumorigenesis in nude mice (4) . Another study observed survival rates no higher than 30% among human lung carcinoma epithelial cells (A549) exposed to photodynamic therapy for 4 h (5). Recently, our group has successfully confirmed that blue light can enhance the proliferation inhibition of HL60 cells treated by all-trans retinoic acid/nanodiamonds (6) . However, the pro-apoptotic effects of blue light on promyelocytic leukemia cells and related mouse models, as well as the possible mechanisms, have not yet been reported.
Pro-apoptotic factors activate mitochondrial apoptotic signaling pathways, which lead to the excessive opening of mitochondrial permeability transition pores (MPTPs). This excessive pore opening causes the dissipation of mitochondrial membrane potential (MMP) across the inner mitochondrial membrane, efflux of Ca 2+ , uncoupling of the respiratory chain and production of superoxide (7, 8) . Subsequently, these changes enhance the release of cytochrome c, apoptosis-inducing factor and B-cell lymphoma-2 (Bcl-2) family proteins from the mitochondria into the membrane space, thus triggering the cell to enter apoptosis.
Bcl-2 family proteins localize within the mitochondria and appear to regulate mitochondrial outer membrane permeability by binding to mitochondrial channels (9) . Bcl-2-associated X protein (Bax) induces the cytoplasmic release of mitochondrial mediators such as cytochrome c, which serves as a marker of mitochondrial injury and is involved in the caspase-dependent apoptosis pathway (10) . Moreover, the mitochondrion is the major site of reactive oxygen species (ROS) generation (11) . Apoptosis can be triggered both by ROS-induced abnormal gene expression and the blockage of cell communication (12) .
This study aimed to investigate the potential systematic effects of blue light therapy for APL. Lactate dehydrogenase (LDH) release assessment. Cells were exposed to blue light and 50 µM of PTX for 24 h, after which the concentrations of LDH in the culture supernatants were detected using an in vitro Toxicology Assay kit (C0017; Beyotime Biotechnology, Jiangsu, China). Data were expressed in terms of cell mortality, according to the instruction manual.
Cell apoptosis assessment. Cells were exposed to blue light and 50 µM of PTX for 24 h. Subsequently, suspended cells were incubated with Annexin V-FITC and propidium iodide for 10 min at 25˚C in darkness, and then analyzed using a Muse™ Cell Analyzer (EMD Millipore, Billerica, MA, USA) according to the manufacturer's instructions.
MMP assessment. Cells were exposed to blue light and 50 µM of PTX for 24 h, and subsequently incubated with 2 µM of 5,5' , 6,6'-tetrachloro-1,1', 3,3'tetraethylbenzimidazol-ylcarbocyanine iodide (JC-1; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for 20 min at 25˚C in darkness. Changes in the levels of red and green fluorescence were detected using a Muse™ Cell Analyzer (EMD Millipore).
ROS assessment. Cells were exposed to blue light and 50 µM of PTX for 24 h, followed by 10 µM of 2'-7'-dichlorodihydrofluorescein diacetate (DCFH-DA; Sigma-Aldrich; Merck KGaA) at 37˚C for 10 min in darkness. Changes in the levels of green fluorescence were detected using a Muse™ Cell Analyzer (EMD Millipore).
HL60-xenografted tumor mouse model. The animal experimental protocol was approved by the Animal Ethics Committee of Jilin University, and all experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications no. 8023, 1978 revision). Five-week-old male BALB/c nude mice (Vital River Laboratory Animal Technology Co., Ltd., Beijing, China) were housed in groups of three in cages exposed to a 12-h light/dark cycle (lighted from 7:00 a.m. to 7:00 p.m.) at 23±1˚C. Water and food were available ad libitum.
HL60 cells were harvested from mid-log-phase cultures, and 0.1 ml of cell suspension (1x10 8 cells/ml) was subcutaneously (s.c.) injected into the right abdomen of each mouse. When the tumor diameters reached 3-5 mm, the mice were randomly divided into two groups (n=3) and exposed to normal (CTRL) or blue light for nine days. The body weights and tumor dimensions were measured daily, and the tumor volumes (mm 3 ) were calculated as follows: Length x (width) 2 x0.5. Finally, the mice were sacrificed via injection with 200 mg/kg of pentobarbital, after which the tumors were dissected and liver and kidney tissues were collected.
Histopathological study. Hematoxylin and eosin (H&E) staining was used to assess hepatic and renal histology. Briefly, liver and kidney tissues were fixed in 4% paraformaldehyde for 24 h, and subsequently dehydrated in a stepwise manner using an ethanol gradient (50, 70, 80, 90, 95 and 100%). The dehydrated samples were immersed in xylene for 30 min and incubated overnight in paraffin at 65˚C. Once embedded, the specimens were cut into 4-µm-thick slices using a microtome (Leica, Wetzlar, Germany) and placed on microscopy slides. The sections were deparaffinized with fresh xylene for 10 min, hydrated using an ethanol gradient (100, 90, 80 and 70%) and washed thrice with distilled/deionized water. After staining with H&E, the sections were examined using an IX73 inverted microscope with a x40 objective (Olympus, Tokyo, Japan).
Western blot. Tumor tissues were lysed using RIPA buffer (Sigma-Aldrich; Merck KGaA) containing a 1% protease inhibitor cocktail (Sigma-Aldrich; Merck KGaA) and 2% PMSF (Sigma-Aldrich; Merck KGaA). Forty micrograms of protein per sample were separated on a 12% SDS-PAGE gel. The proteins were then transferred electrophoretically to 0.45 µm nitrocellulose membranes, which were then incubated overnight with primary antibodies against Bcl-2, Bax, Bcl extra-long (Bcl-xL), cytochrome c, cleaved caspases-3 and -9 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Cell Signaling Technology, Inc., Danvers, MA, USA) at 4˚C (all dilutions: 1:1,000). Subsequently, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) at room temperature for 4 h. An enhanced chemiluminescence detection kit (GE Healthcare, Little Chalfont, UK) was then used to detect the labeled protein bands. The band intensities were quantified using Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis. The data are expressed as means ± standard deviations (SD). Statistical significance was detected using a one-way variance analysis (ANOVA), followed by Dunn's test, using SPSS version 16.0 software (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results

Blue light induced apoptosis in HL60 cells.
We first determined the optimal experimental blue light dose by controlling the exposure duration. Blue light reduced the viability of HL60 cells in a time-dependent manner from 12 to 56 h of exposure (P<0.001; Fig. 1A ). Both PTX and a 24-h exposure to blue light reduced cell viability by >50% (P<0.001; Fig. 1B) . The cell mortality rate was determined by LDH release, which was enhanced significantly in HL60 cells exposed to blue light for 24 h (Fig. 1C) .
Apoptosis rates of 81.8 and 68.3% were observed among cells exposed to PTX (50 µM) and blue light, respectively, for 24 h (Fig. 2A) . Moreover, compared with the control cells, PTX or blue light treatment led to MMP depolarization rates of 72.5% (63.65 vs. 17.45%) and 65.6% (50.85 vs. 17.45%) (Fig. 2B) , which further promoted the apoptosis of HL60 cells.
In addition, ROS-mediated late mitochondrial events (13) were found to be strongly enhanced in HL60 cells exposed to blue light and PTX treatment (Fig. 2C) .
Blue light suppressed tumor growth in nude mice. Blue light exhibited significant antitumor activity against HL60-xenografted tumors in a nude mouse model. A 9-day exposure to blue light strongly suppressed tumor growth without affecting the body weights of the mice, indicating that blue light has few side effects in normal tissues (Fig. 3A-C) . A histopathological study in which few pathologic changes were observed between the livers and kidneys of blue-light exposed and non-exposed mice further confirmed the safety of blue light therapy ( Fig. 3E and F) . Sixteen days after tumor implantation, the tumors began to grow rapidly in the non-treated control mice, reaching a mean tumor volume of 975.5±283.4 mm 3 . In contrast, tumor growth was strongly inhibited in blue light-treated mice, beginning on day 7 (P<0.05; Fig. 3D ).
Blue light regulated the expression of pro-and anti-apoptotic proteins.
Compared with the non-treated mice, the tumor tissues of the blue light-treated mice exhibited significantly reduced expression of Bcl-2 and Bcl-xL and enhanced expression of Bax, cytochrome c and cleaved caspases-3 and -9 (P<0.05; Fig. 4 ). The Bcl-2/Bax ratio was 13.8% higher in the tumor tissues of the blue light-exposed mice, compared to the non-exposed mice (Fig. 4) .
Discussion
In the present study, we have clarified the pro-apoptotic effects of blue light therapy and the underlying mechanisms in HL60 cells. We selected a 24-h exposure duration to investigate the mechanism underlying blue light-induced apoptosis in these cells. LDH is enriched in the cytoplasm and normally cannot pass through the membrane; however, cell damage causes a release of LDH into the extracellular space (14) . We observed that blue light reduced the viability of HL60 cells in a time-dependent manner from 12 to 56 h, as indicated by the release of LDH.
A normal MMP is required to maintain oxidative phosphorylation and adenosine triphosphate (ATP) formation (7) . A stable MMP thus confers a survival advantage upon the cell. Changes characteristic of mitochondrial apoptosis are commonly observed during cell apoptosis, which is characterized by the disruption of the MMP (15). In our study, blue light treatment caused depolarization of the MMP and thus promoted HL60 cell apoptosis. This process occurred before deoxyribonucleic acid fragmentation. As reported previously, ROS and mitochondria are linked by a short feedback loop as indicated by the cytoplasmic overproduction of ROS during mitochondria-dependent apoptosis, which further promotes the opening of the MPTP (16, 17) . Our data suggest that blue light-mediated apoptosis in HL60 cells may involve the ROS-mediated mitochondrial apoptosis pathway.
Moreover, our in vivo data are consistent with those of in vitro investigations. The antitumor activity of blue light was further confirmed by our finding that blue light exposure strongly suppressed tumor growth without affecting the body weights of mice. Caspase-3, an important effector related to cell morphology and certain biochemical events associated with apoptosis, is catalyzed by activated caspase-9 (18), and ROS was identified as necessary for the full activation of the caspase cascade (13) . Additionally, Bcl-2 family proteins, which serve as biomarkers of mitochondrial function, have become targets for anti-tumor agents. Specifically, the expression levels of Bcl-2 and Bax are used to determine whether the mitochondrial apoptosis pathway has been activated (19) , and a heterodimer of Bcl-2/Bax is known to regulate the MMP (20) . Our related data further confirm that the pro-apoptotic effects of blue light in HL60 cells may be associated with the mitochondrial pathway.
There are still several limitations in our present study. Firstly, the effects of blue light were not measured in normal cells; however, the histopathological study on livers and kidneys of nude mice has confirmed the safety of blue light therapy. Secondly, although the APL mouse model has been successfully established in our group, it failed to perform in the present study. The tumor bearing mice model established by HL60 cells applied in this experiment has been used for other previous studies (21) , which can also certify the pro-apoptotic effects of blue light in human promyelocytic leukemia. Moreover, our present data failed to systemically discuss the correlation between MMP depolarization and ROS production during blue light mediated pro-apoptosis in HL60 cells. Blue light caused the changes on the expression levels of other Bcl-2 family members such as Bim and Bak will be detected in further experiments. N-Acetyl-L-cysteine (NAC), a ROS scavenger, will be applied to investigate its influence on the pro-apoptotic effects of blue light, and the translocation of Cytoplasma C from mitochondria to cytosol will be detected in cells in our ongoing experiments related to the effects of blue light.
In conclusion, our experimental findings verified the pro-apoptotic effects of blue light in both in vitro and in vivo models. Blue light exposure induced the excess release of LDH and depolarization of the MMP in HL60 cells, suppressed the growth of HL60-xenografted tumors and regulated the expression of both pro-and anti-apoptotic proteins in tumor tissues. Taken together, our data suggest that blue light induces apoptosis in tumor cells via the mitochondrial apoptosis pathway. Our findings provide pharmacological evidence of the potential usefulness of blue light as an adjuvant therapy for leukemia.
